TargetIntegrin alpha-V/beta-5(Homo sapiens (Human))
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Johnson And Johnson Pharmaceutical Research & Development
Curated by ChEMBL
Affinity DataIC50: 420nMAssay Description:In vitro inhibition of human alphaV-beta5 integrin binding in ELISAMore data for this Ligand-Target Pair